df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.1 KiB
7.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND SECTION 39-24-20, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING TO DEFINITIONS IN THE DRUG PRODUCT SELECTION ACT, SO AS TO CHANGE THE DEFINITION OF "SUBSTITUTE" TO INCLUDE INTERCHANGEABLE BIOLOGICAL PRODUCTS; TO AMEND SECTION 39-24-30, RELATING TO THE SUBSTITUTION OF EQUIVALENT DRUGS, SO AS TO ALLOW A PHARMACIST TO SUBSTITUTE AN INTERCHANGEABLE BIOLOGICAL PRODUCT FOR A SPECIFIC BIOLOGICAL PRODUCT; TO AMEND SECTION 39-24-40, AS AMENDED, RELATING TO THE SUBSTITUTION OF PRESCRIPTIONS BY PHARMACISTS, SO AS TO ALLOW PHARMACISTS TO SUBSTITUTE INTERCHANGEABLE BIOLOGICAL PRODUCTS WHEN APPROPRIATE; TO AMEND SECTION 40-43-30, RELATING TO DEFINITIONS IN THE PHARMACY PRACTICE ACT, SO AS TO ADD DEFINITIONS FOR "BIOLOGICAL PRODUCT" AND "INTERCHANGEABLE BIOLOGICAL PRODUCT"; AND TO AMEND SECTION 40-43-86, RELATING IN PART TO LABEL REQUIREMENTS FOR PRESCRIPTIONS, SO AS TO ADDRESS LABELING, PRESCRIBER NOTIFICATION, AND OTHER REQUIREMENTS APPLICABLE TO INTERCHANGEABLE BIOLOGICAL PRODUCTS. - ratified title | AN ACT TO AMEND SECTION 39-24-20, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING TO DEFINITIONS IN THE DRUG PRODUCT SELECTION ACT, SO AS TO CHANGE THE DEFINITION OF "SUBSTITUTE" TO INCLUDE INTERCHANGEABLE BIOLOGICAL PRODUCTS; TO AMEND SECTION 39-24-30, RELATING TO THE SUBSTITUTION OF EQUIVALENT DRUGS, SO AS TO ALLOW A PHARMACIST TO SUBSTITUTE AN INTERCHANGEABLE BIOLOGICAL PRODUCT FOR A SPECIFIC BIOLOGICAL PRODUCT; TO AMEND SECTION 39-24-40, AS AMENDED, RELATING TO THE SUBSTITUTION OF PRESCRIPTIONS BY PHARMACISTS, SO AS TO ALLOW PHARMACISTS TO SUBSTITUTE INTERCHANGEABLE BIOLOGICAL PRODUCTS WHEN APPROPRIATE; TO AMEND SECTION 40-43-30, RELATING TO DEFINITIONS IN THE PHARMACY PRACTICE ACT, SO AS TO ADD DEFINITIONS FOR "BIOLOGICAL PRODUCT" AND "INTERCHANGEABLE BIOLOGICAL PRODUCT"; AND TO AMEND SECTION 40-43-86, RELATING IN PART TO LABEL REQUIREMENTS FOR PRESCRIPTIONS, SO AS TO ADDRESS LABELING, PRESCRIBER NOTIFICATION, AND OTHER REQUIREMENTS APPLICABLE TO INTERCHANGEABLE BIOLOGICAL PRODUCTS. - ratified title | us/states/sc | South Carolina General Assembly | 2017-2018 | H 3438 | South Carolina H 3438 (2017-2018) |
|
enacted |
|
6 | 25 | 3 | 2017-01-12 | 2017-04-28 | openstates | ocd-bill/99499a70-61b6-4de7-99bf-9e5efc037b52 | http://www.scstatehouse.gov/billsearch.php?billnumbers=3438&session=122&summary=B | 023f0ed2384575a4528a97a5713da2d12d816f84af51874f969ec33f44a50e77 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
South Carolina H 3438 (2017-2018) — AN ACT TO AMEND SECTION 39-24-20, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING TO DEFINITIONS IN THE DRUG PRODUCT SELECTION ACT, SO AS TO CHANGE THE DEFINITION OF "SUBSTITUTE" TO INCLUDE INTERCHANGEABLE BIOLOGICAL PRODUCTS; TO AMEND SECTION 39-24-30, RELATING TO THE SUBSTITUTION OF EQUIVALENT DRUGS, SO AS TO ALLOW A PHARMACIST TO SUBSTITUTE AN INTERCHANGEABLE BIOLOGICAL PRODUCT FOR A SPECIFIC BIOLOGICAL PRODUCT; TO AMEND SECTION 39-24-40, AS AMENDED, RELATING TO THE SUBSTITUTION OF PRESCRIPTIONS BY PHARMACISTS, SO AS TO ALLOW PHARMACISTS TO SUBSTITUTE INTERCHANGEABLE BIOLOGICAL PRODUCTS WHEN APPROPRIATE; TO AMEND SECTION 40-43-30, RELATING TO DEFINITIONS IN THE PHARMACY PRACTICE ACT, SO AS TO ADD DEFINITIONS FOR "BIOLOGICAL PRODUCT" AND "INTERCHANGEABLE BIOLOGICAL PRODUCT"; AND TO AMEND SECTION 40-43-86, RELATING IN PART TO LABEL REQUIREMENTS FOR PRESCRIPTIONS, SO AS TO ADDRESS LABELING, PRESCRIBER NOTIFICATION, AND OTHER REQUIREMENTS APPLICABLE TO INTERCHANGEABLE BIOLOGICAL PRODUCTS. - ratified title
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- 1/12/2017 (committee substitute) — source
- 2/15/2017 (committee substitute) — source
- 2/21/2017 (committee substitute) — source
- 2/22/2017 (committee substitute) — source
- 3/16/2017 (committee substitute) — source
- 3/23/2017 (committee substitute) — source
Votes
- Passage of Bill — 104–0 (pass) · lower
- Concur in Senate Amendments — 95–0 (pass) · lower
- 2nd Reading — 37–0 (pass) · upper
Sponsors
- G.M. Smith — primary (person)
- Henderson — primary (person)
- Hiott — primary (person)
- Loftis — primary (person)
- Robinson-Simpson — primary (person)
- Sandifer — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2017-01-12 Introduced and read first time
introduction, reading-1 - 2017-01-12 Referred to Committee on Medical, Military, Public and Municipal Affairs
referral-committee - 2017-01-18 Member(s) request name added as sponsor: G.M.Smith
- 2017-01-19 Member(s) request name added as sponsor: Sandifer, Hiott
- 2017-02-15 Committee report: Favorable with amendment Medical, Military, Public and Municipal Affairs
committee-passage-favorable - 2017-02-21 Member(s) request name added as sponsor: Loftis
- 2017-02-21 Amended
amendment-passage - 2017-02-21 Read second time
reading-2 - 2017-02-21 Roll call Yeas-104 Nays-0
- 2017-02-21 Member(s) request name added as sponsor: Robinson-Simpson
- 2017-02-22 Read third time and sent to Senate
passage, reading-3 - 2017-02-22 Introduced and read first time
introduction, reading-1 - 2017-02-22 Referred to Committee on Medical Affairs
referral-committee - 2017-02-22 Scrivener's error corrected
- 2017-03-16 Committee report: Favorable with amendment Medical Affairs
committee-passage-favorable - 2017-03-23 Committee Amendment Adopted
amendment-passage - 2017-03-23 Read second time
reading-2 - 2017-03-23 Roll call Ayes-37 Nays-0
- 2017-03-29 Read third time and returned to House with amendments
passage, reading-3 - 2017-04-04 Concurred in Senate amendment and enrolled
- 2017-04-04 Roll call Yeas-95 Nays-0
- 2017-04-19 Ratified R 20
- 2017-04-24 Signed By Governor
executive-signature - 2017-04-27 Effective date 4/24/17
- 2017-04-28 Act No. 11
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/99499a70-61b6-4de7-99bf-9e5efc037b52. Confidence: reported (aggregated from official South Carolina legislature records).